A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market [Yahoo! Finance]
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: Yahoo! Finance
Cardiovascular disease may be one of medicine's oldest battlegrounds , but some of its most important technologies are still evolving — and not always as quickly as patients, and investors, might expect. Nowhere is that more evident than in transcatheter aortic valve replacement (TAVR), a market dominated for more than a decade by two global giants: Edwards Lifesciences Corp (NYSE:EW, XETRA:EWL) and Medtronic PLC (NYSE:MDT, XETRA:2M6) . Their flagship devices — Sapien and Evolut — have transformed the treatment of aortic stenosis , a life-threatening narrowing of the aortic valve that restricts blood flow and can lead to heart failure or death if left untreated. Yet those devices, for all their success, still reflect incremental design changes — and force clinicians to navigate trade-offs between ease of use and optimal performance. At the same time, their expanded use in lower-risk and younger patient populations is creating a new unmet need, as patients live longer and, in some
Show less
Read more
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- Edwards Lifesciences (EW) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $92.00 price target on the stock.MarketBeat
- Boston Scientific: From Hypergrowth To Durable Compounding [Seeking Alpha]Seeking Alpha
- Philips Wins FDA 510(k) Clearance for AI Heart Valve Repair Solution [Yahoo! Finance]Yahoo! Finance
- Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits [Yahoo! Finance]Yahoo! Finance
- Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient BenefitsBusiness Wire
EW
Earnings
- 2/10/26 - Miss
EW
Sec Filings
- 4/2/26 - Form 4
- 3/26/26 - Form SCHEDULE
- 3/26/26 - Form ARS
- EW's page on the SEC website